(Q24187283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

1 reference

title

Pharmacological interventions for pain in children and adolescents with life-limiting conditions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Emma Beecham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bridget Candy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Richard Howard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Renée McCulloch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jo Laddie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Henrietta Rees

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Myra Bluebond-Langner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Louise Jones

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

13 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

CD010750

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Impact of alendronate on quality of life in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Osteogenesis imperfecta and intravenous pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Efficacy of alendronate in the treatment of low bone density in the pediatric and young adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Intravenous bisphosphonate therapy in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Transdermal fentanyl in the management of children with chronic severe pain: results from an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Neridronic acid for the treatment of bone metabolic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Advantages of fentanyl over morphine in analgesia for ventilated newborn infants after birth: A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Paracetamol (Acetaminophen): mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

End of life in children with cancer: experience at the pediatric oncology department of the istituto nazionale tumori in Milan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

The symptoms of dying children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Rising national prevalence of life-limiting conditions in children in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Patterns of diagnoses among children and young adults with life-limiting conditions: A secondary analysis of a national dataset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Symptoms in children/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses Forum survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Transdermal fentanyl for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Paediatric palliative care: development and pilot study of a 'Directory' of life-limiting conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Parents' perspective on symptoms, quality of life, characteristics of death and end-of-life decisions for children dying from cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Palliative care for infants, children, adolescents, and their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Pain control: non-steroidal anti-inflammatory agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Pharmacological treatment of chronic non-cancer pain in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Bisphosphonate therapy for osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

The PedsQL: measurement model for the pediatric quality of life inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children's self-reports of pain intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Symptoms and suffering at the end of life in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Pediatric palliative care: use of opioids for the management of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010750.PUB2

Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study

21 January 2018

1 reference

12 December 2020

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

1 reference

12 December 2020

[Treatment of pain in a case of osteogenesis imperfecta type III]

1 reference

12 December 2020

The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta.

1 reference

12 December 2020

Symptoms Affecting Children With Malignancies During the Last Month of Life: A Nationwide Follow-up

1 reference

12 December 2020

Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen

1 reference

12 December 2020

Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment

1 reference

12 December 2020

Upper-Limb Botulinum Toxin A Injection and Occupational Therapy in Children With Hemiplegic Cerebral Palsy Identified From a Population Register: A Single-Blind, Randomized, Controlled Trial

1 reference

12 December 2020

Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study

1 reference

12 December 2020

Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta

1 reference

12 December 2020

GRADE: assessing the quality of evidence for diagnostic recommendations

1 reference

12 December 2020

New trends in the treatment of osteogenesis imperfecta type III - own experience

1 reference

12 December 2020

Osteogenesis imperfecta

1 reference

12 December 2020

Cyclic pamidronate therapy in children with osteogenesis imperfecta.

1 reference

12 December 2020

Pediatric palliative care patients: a prospective multicenter cohort study

1 reference

12 December 2020

Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study

1 reference

12 December 2020

Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta

1 reference

12 December 2020

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes

1 reference

12 December 2020

Pain in children: comparison of assessment scales

1 reference

12 December 2020

Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta

1 reference

12 December 2020

10.1002/14651858.CD010750.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25768935%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

25768935

1 reference